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BRAIN DEATH, ETHICS COMMITTEES
& COURTS
The case of 13 year old Jahi McMath
has been widely reported in the media.
Jahi had her tonsils, adenoids, and extra
sinus tissue removed on December 9,
2013 to treat sleep apnea. She suffered
a hemorrhage and subsequent cardiac
arrest and was pronounced brain dead
in a California hospital on December
12, 2013. However, her parents sought
court intervention to continue ventilator
support and tube feedings as they hoped
for a miracle to bring her back to life.
This case raises questions about how
far we should go to assuage the grief of
bereaved family members when a patient
has died.
For decades in the U.S. and other
countries, a person who is pronounced
dead by neurologic criteria (i.e.,
“brain dead” – no response to pain, no
cranial nerve reflexes, no spontaneous
respirations) is considered legally
dead. This allows for organs of the
deceased to be donated, death rituals to
be enacted, and medical resources to be
freed up for other patients who stand to
benefit. Family members are generally
provided a short period of time to “say
goodbye” before medical interventions
(e.g., ventilator, intravenous fluids or
tube feedings) are stopped. This usually
occurs within hours of the brain death
diagnosis. The McMath case is unusual
in that the family requested that Jahi
continue to receive medical technologies
after being pronounced dead, and a judge
granted that request.
How might you handle such a case if
it came before your ethics committee?

While patients are routinely pronounced
dead by neurologic criteria at acute
care hospitals, it’s a rare event for a
child undergoing routine surgery to
die. Questions about usual surgical risk
versus medical error are likely to come
up, and thus it would be appropriate to
involve risk management. If medical
error may have contributed to the
patient’s death, staff should implement
standard protocols for error disclosure
(Bell et al., 2010; Petronio et al., 2013;
ToughTalk, n.d.). All hospitals in
Maryland are required to have a patient
safety program in place that, among
other things: identifies, assesses and
responds to near-misses and adverse
events relating to patient care; conducts
root cause analyses; and reports required
information to the Maryland Department
Cont. on page 2
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Brain Death
Cont. from page 1
of Health and Mental Hygiene (Md.
Code Ann. 2013).
It may be tempting in such cases
to defer to loved ones to “give them
as much time as they need” to grieve
before stopping medical technology,
but this would run counter to the
principle of justice in ethics that
requires “treating like cases alike.”
Furthermore, while hospice and
palliative care providers often report
implementing certain interventions
more to benefit the dying patient’s
family members than the patient,
the point at which a dead body is
subjected to medical technology
intended only for the living purely
to ease the grief of the family raises
the concern of disrespecting the body
by using it solely as a means to the
family members’ emotional ends. How
family members are respected and
emotionally supported to minimize
their regrets and assist in their grieving
process is pivotal. However, the
assumption that “doing whatever
the family asks” is the best way to
provide such support is untested, and
thus should be challenged. Death of
a loved one is often met by anguish
and demands from the bereaved to
“do everything,” but sometimes it is
human compassion and connection,
rather than medical technology, that is
required to help heal a broken heart.
Can there be another interpretation
of “doing everything” in such
cases? What might this look like in

the context of ethics consultation?
Ethics consultants called in on such
a case should facilitate meaningful
communication among those involved
to ensure that the staff’s empathy
and regret have been expressed to
the family, that the accuracy of the
diagnosis of brain death has been
clearly explained, and that the parents’
concerns are heard. Assuming that best
efforts are undertaken to communicate
effectively with the parents and to
establish trust and provide emotional
support, and yet the parents continue
to insist that the ventilator and tube
feedings be maintained indefinitely, it
would be appropriate to recommend
that the hospital set a date to stop
the ventilator and tube feedings
according to the medical standard
of care. Stopping a ventilator after
pronouncing death is a routine
medical procedure, and thus not
typically handled as a certification of
medically ineffective treatment under
Maryland’s Health Care Decisions
Act (HCDA). However, whether or
not the process defined in Maryland’s
HCDA is followed, the parents have
a right to pursue court intervention.
This is an appropriate due process
“check and balance” that helps protect
the rights of those low in the power
hierarchy. Unfortunately, not all judges
are equally versed in bioethics, and
thus it would be important for the
ethics committee to include sufficient
background and justification to support

Faculty from Union Graduate College-Icahn School of Medicine
at Mount Sinai Bioethics Program have introduced a novel,
asynchronous "online symposium" on the McMath and Munoz cases
on their program's blog. The McMath case is featured in this issue's
lead article. The Munoz case involved a pregnant Texas woman
whose body was maintained on a ventilator, with artificial nutrition/
hydration, against her family's wishes, based on the hospital's
interpretation of Texas law. These cases raise questions about the
role of court involvement in end-of-life decision-making, particularly
regarding determinations of brain death. Access the symposium by
searching "McMath Munoz online symposium" in Google.

its recommendation, and to provide
this to the judge.
It’s unclear whether an ethics
committee was consulted in the
McMath case. Perhaps this may have
changed the course of events. Due
to the media attention, the case was
erroneously covered as a “right-tolife” case and funds were donated to
support care for Jahi’s body outside
of the hospital at an undisclosed
long-term care facility. The family
reports taking time away from the
media spotlight to “heal up.” One
wonders whether the same could have
been achieved with more effective

communication and support for both
family and staff. Clearly, more needs
to be done to educate the public, the
press, and health care providers about
goals and limits of medicine at the end
of life.
Anita J. Tarzian, PhD, RN
MHECN Program Coordinator
Associate Professor, University of
Maryland School of Nursing
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Death of a loved one is often met by anguish and demands from the bereaved to “do everything,” but
sometimes it is human compassion and connection, rather than medical technology, that is required to help
heal a broken heart.

MOLST CONFERENCE FOCUSES ON SUCCESSES
AND CHALLENGES
On December 9, 2013, MHECN
and Harbor Hospital co-sponsored
the conference, Maryland Medical
Orders for Life-sustaining Treatment
(MOLST): A six month check-up,
at the UM Carey School of Law.
The focus of the conference was on
successes and challenges encountered
in implementing the MOLST form in
Maryland healthcare facilities.
Anonymous online survey data
presented at the conference revealed
reasons for both satisfaction and
dissatisfaction with the MOLST
form. Satisfied users pointed to the
form being completed correctly at
their institution (e.g., the form is on
patients’ charts and sent out with
transfers), and the form actually
improving patient care (e.g., by
opening up dialogue with patients
and family about end of life issues,
increasing awareness of assigning a
health care agent or completing an
advance directive, and helping avoid

unwanted and
unnecessary
medical care).
The satisfied
users tended to
report having a
process in place
at their facility to
ensure successful
MOLST
implementation
(e.g., educating
all parties on
the process,
getting buy-in
from administration to hold clinicians
accountable for completing MOLST
forms on the initial visit to the facility,
and replacing the system Do-NotAttempt-Resuscitation order with the
MOLST form).
Dissatisfied users identified
problems with how clinicians
completed the form (e.g., the wrong
or no decision-maker was identified,

the form was not signed, conflicting
preferences selected such as “palliative
care” on page 1 but “do everything”
on p. 2, and the form was not sent with
the patient when it should have been).
In addition, they identified instances
where (1) the form did not reflect the
patient’s wishes (e.g., patients did
not remember discussing the form or
didn’t agree with how it was filled
Cont. on page 4
Mid-Atlantic Ethics Committee Newsletter 3

MOLST
Cont. from page 3
out; (2) surrogates overrode MOLST
orders; (3) clinicians defaulted to
full cardio-pulmonary resuscitation
(CPR) without discussing this with
the patient, simply assuming that
the patient would want to be a full
code.); and (4) the MOLST form
was inappropriately voided by a
clinician (e.g., one clinician takes
time to complete a MOLST form
after discussion with a patient and
another clinician completes a new
MOLST form with no clear indication
that the latter MOLST form reflects
the patient’s wishes more accurately
than the prior form). Other barriers to
successful implementation included
clinician errors interpreting the
MOLST form, difficulty finding the
most recently completed MOLST
form, and concerns that the completed

form was inconsistent with Maryland’s
Health Care Decisions Act (e.g.,
by not recognizing the authorized
decision maker for an incapacitated
person, or overlooking procedures
to certify medical conditions such as
decisional incapacity, an end-stage
or terminal condition or persistent
vegetative state, or treatments
considered medically ineffective).
Perceived barriers to effective
MOLST implementation include
poor end-of-life communication
skills among clinicians explaining
MOLST to patients and families and
clinicians completing the MOLST
form, perceived lack of time among
health care providers to complete the
MOLST form, lack of buy-in from
physicians and other key stakeholders
regarding the MOLST process,

clinicians not trusting the MOLST
order form, and difficult timing of endof-life decision-making in acute care
settings. Many identified a functioning
state MOLST and advance directive
registry as a necessary step to ensure
successful MOLST implementation.
Conference speakers presented
strategies to address barriers to
effective MOLST implementation,
including communication skills and
organizational approaches to effective
MOLST adoption. Video-recordings of
the conference sessions are available
on MHECN’s website at http://www.
law.umaryland.edu/mhecn (click on
Conferences).

ELEVENTH HOUR
by K.D. Hayes

Reprinted with permission from Pulse—voices from the heart of medicine, which reveals the personal side of health care
through weekly stories, poems and images. Subscribe at pulsevoices.org.
Uncle Walt died this morning.
Finally.
I say "finally" because I believed
this day would come four months
ago, when he had emergency bypass
surgery.
At the time, I didn't believe Walt
would live; he was an ailing, seventyseven year-old man with severe
pulmonary disease. When his heart
started to hurt one Friday, his doctors
told him, "With bypass surgery, you
might live. Without it, you'll be dead
before the weekend is over."
Walt's oldest daughter and my
parents, who were with him, told me
about the doctors' recommendations.
As a retired paramedic, I'd seen this
scenario before—often enough to have
a strong opinion, and my own advance
directives.
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I didn't think that Walt should have
the surgery. I thought it would cost
too much suffering and money and
ultimately lead to the same predictable
outcome. I expressed concern that the
medical community was pushing, even
coercing, Walt to agree to surgery.
My parents assured me that Walt
understood the severity of his
condition. He knew that he was a poor
surgical candidate, that he might not
survive the surgery, that he would
suffer.
And Walt said, "I want to live."
I disagreed with Walt's choice for
another reason: I believed that it
would thrust suffering upon his family
members, who were also my loved
ones.
His four children, who said he'd
abused and molested them, would

suffer, dragged into advising and
decision-making roles. My father
would suffer because he loved his
older brother deeply—despite my
cousins' assertions and despite Walt's
drinking away the first decades of
his life, failing to find a successful
career, and heading a family driven by
dysfunction.
Walt had made our whole family
suffer, and I didn't want him to cause
more suffering. I felt angry with him.
Over the years, his declarations of
remorse had seemed insincere, his
oblique admissions and apologies
insufficient to heal his children's
wounds. I felt he'd given them good
reason to leave him. And though
he had never mistreated me, I'd
maintained a cool reserve.
In the end, Walt had the surgery—

But what came of those days between the time I thought my uncle would die and the time, four months
later, when he did die? Those expensive, painful days, dogged by fear and anxiety, when my cousins were
spent and my parents exhausted, when Walt could have died but lived instead? Walt found God.
and lived through it, although
sometimes it hardly seemed living.
Essentially, his bypass saved his
heart so that his lungs could kill
him. He had a breathing tube in his
windpipe and a feeding tube in his
stomach; he lived through a week
of "ICU psychosis," tormented by
hallucinations. After he'd spent nearly
a month in surgical intensive care,
they moved him to an extended acutecare hospital, then to a skilled-nursing
facility.
He had good days—a few. He taught
his tired larynx to form words again.
He progressed from sitting in a chair
to standing to walking a few steps.
Once, he walked all the way from his
room to the lobby and back. He also
had many bad days, when he couldn't
even get out of bed. He suffered
persistent urinary-tract and C. difficile
infections. Whenever it seemed that
Walt's body might give up the fight for
life, the staff would ask Walt whether
he wanted to be resuscitated.
He always said, "I want to live."
It was his decision; I don't think it
would have been mine.
But what came of those days
between the time I thought my
uncle would die and the time, four
months later, when he did die? Those
expensive, painful days, dogged by
fear and anxiety, when my cousins
were spent and my parents exhausted,
when Walt could have died but lived
instead?
Walt found God. On the night before
his surgery, the fear of death opened
up a vulnerability in him, and he
accepted a priest—and then God. He
confessed. That night, with two of his
four children by his side, he wept his
confession.
My cousin recorded his father's
words in a journal: "Forgive me for
the abuse....I abused all of you. I wish

I had been a better man." Walt asked
his children for forgiveness, and they
gave it.
My cousin emailed this exchange to
his brother and sisters, to his mother
and aunts and uncles and cousins.
The next morning, huddling with my
parents and cousins beside Walt, who
lay unconscious after the operation, I
did not know how to carry my anger.
But the months that followed gave
my father more time to spend with his

older brother.
"Such a beautiful gift, this time,"
my father says now, even though those
days also sucked away my parents'
energy.
I doubt that Walt expected that his
family would start healing--that his
act of contrition would forge new
bonds of obligation, responsibility and
caring.
But because the operation gave him
those months after his "deathbed"
confession, his children were able to
tell him that they loved him; and their
words resonated with a new truth.
"We thanked him and told him he
had given us a gift," my cousin wrote.
Several days after Walt's surgery,
I stood by his bed and held his
hand as he drifted into and out of
consciousness.
His oldest daughter stood beside me.
Whenever Walt was awake, he'd look
at her and mouth the words "I love

you." I felt I was watching them forge
a new relationship.
Walt's fractured, estranged family
began reaching out, emailing or
calling, traveling, reconnecting with
each other—and even with Walt. I
heard words of remorse, excruciating
admissions, and gradually my anger
subsided into awe.
I feel certain that Walt knew of the
evolution that began in his family that
dark night before his surgery, when he
felt sure that he would die.
This morning, when Walt finally
did die, he left behind a different
life—and a different family. His oldest
daughter stood in his hospital room,
her boyfriend's arm through hers. Her
two adult children hovered near their
grandfather. My aunt stood at the foot
of his bed. I knelt by the railing, my
parents standing just behind me.
I held Walt's hand and told him that
it was okay to go—and that I loved
him. Four months earlier, I'd thought
the most pragmatic, least painful
choice he could make would be not to
fight for life. I'd thought it would be
easier, kinder for everyone.
When is the right time to die?
I used to believe that I knew.
Just after Walt's surgery, I made
plans to fine-tune my own advance
directives—to forbid intubation or
stomach tubes.
But I have yet to call my lawyer.
I'm no longer so certain that choosing
a quick, efficient death is selfless and
honorable.
Now I know that my choice to
die won't be just about me. And that
changes everything.
A writer and retired paramedic, K.D.
Hayes has an MA in interdisciplinary
studies and an MFA in creative
writing.
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ONE MARYLAND HOSPITAL’S APPROACH
TO MEDICALLY INEFFECTIVE TREATMENT
The responsibility to preserve human life through medical science has moral limits. Extraordinary means that may not
alleviate the underlying condition and may excessively burden the patient are not obligatory. Moral decisions about the
extent of care should be made in terms of the benefit that may be offered and the burdens that may be imposed, assisted by
the medical professional’s judgments and a person’s sense of what is appropriate. - Maryland Catholic Conference- End
of Life, www.mdcathcon.org/endof life.
At the December 9, 2013 conference
co-sponsored by MHECN and
Harbor Hospital, Maryland Medical
Orders for Life-sustaining Treatment
(MOLST): A six month check-up,
Lee Schwab, MD, FCCP, chair of
the ethics committee at Holy Cross
Hospital, presented his hospital’s
approach to requests to provide
medically ineffective treatment. One
of the more common reasons for an
ethics consult in Holy Cross’s adult
inpatient population is moral distress
among staff when negotiations over
the care of dying patients breaks
down and family members insist that
their loved one continue to receive
interventions that physicians have
determined are medically ineffective
in achieving the goals of care. Reasons
for cases like these are familiar to
ethics committee members: there is
an increasing number of terminally
ill patients admitted to intensive
care units without appropriate prior
end-of-life planning; physicians of
diverse cultural origins let patients/
family members choose which
medical interventions to pursue
without identifying goals of care and
without restrictions on treatments
unlikely to achieve the goals of care;
physicians view their prime ethical
duty as advocating for the individual
patient rather than stewardship to
the institution and the community;

physicians and patients alike shy away
from open discussions about death,
dying, and goals of care at the end of
life; and physicians tend to acquiesce
to patient/family demands for fear
of the time and expense involved if
they get sued. There was (and still
is) misperception among physicians
and members of the community that
patients/surrogates have the right to
demand all medical interventions.
Until recently, physicians have had
little incentive to concern themselves
with limiting non-beneficial treatment
because they have been reimbursed
for the additional acute care services
provided to dying patients. The
hospital, on the other hand, places
itself in financial jeopardy when
resource-intensive, non-reimbursable,
non-beneficial treatments are provided
on demand. Attention to financial
sustainability is often downplayed in
clinical ethics due to concerns that
ethicists and clinicians should not
“ration at the bedside.” However,
there is growing recognition that
stewardship of finite medical resources
is an important component of ethical
analysis that should not be excluded
in ethics case consultations. While
withholding or withdrawing medically
ineffective treatment can be justified
for reasons other than resource
stewardship (for example, if it is not in
the patient’s best interests or consistent

with his or her wishes), in some cases
where a surrogate demands medical
interventions for a non-communicative
dying patient that won’t achieve
established goals, clinicians and
ethicists should recognize justice
obligations that are based on
responsible allocation of medical
resources. These obligations must be
balanced by other ethical principles,
such as the duty to minimize regrets
and support the grieving process
of bereaved loved ones. Thus, how
institutions approach withholding or
withdrawing non-beneficial treatments
is critical to avoid the pendulum
swinging from over-treatment at the
end of life to under-treatment.
Holy Cross Hospital addressed this
challenge at the organizational level.
First, the ethics committee obtained
feedback from staff revealing that
physicians, in particular, did not
view the ethics consultation process
as useful in disputes about medical
futility. Physicians perceived that they
were taking most of the risk when
they proceeded with certifications
to withhold or withdraw medically
ineffective interventions from a
patient. Many physicians were
unaware or unconvinced that an ethics
consultation provided them with
liability protection.
The ethics committee proceeded to
address this by obtaining support from

By a show of hands, attendees at the December 9, 2013 MOLST conference supported a process of
establishing a hospital policy and procedure “community standard” in the state to withhold or withdraw
medically ineffective treatment without a patient/surrogate’s consent. This could include clarifying some of
the terms in Maryland’s HCDA, such as the definition of death being “imminent,” a patient being “terminal,”
and what a “reasonable time” is to arrange transfer. It might also address ways to ensure fairness, such as
referral of such cases for ethics consultation.
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senior leadership and hospital counsel
to integrate ethical principles with
the process outlined in the Maryland
Health Care Decisions Act (HCDA).
They created a facility-wide policy
and process to address determinations
of medically ineffective treatment. Dr.
Schwab underscored the importance
of this step: all staff—physicians
in particular—must believe that the
hospital is fully supporting them.
At Holy Cross Hospital, they have
found that physician-to-physician
communication is an important
component of the process. Another
realization involved the greater

comfort level of staff and patients’
family members regarding withholding
non-beneficial treatment rather than
withdrawing treatment. While in ethics
no moral distinction is made between
the two, the reality that these acts feel
different has been incorporated into
Holy Cross’s process by allowing
for “no escalation of treatment”
decisions in some cases, rather than
stopping all life support at once.
Although ideologically imperfect, Dr.
Schwab views this as a worthwhile
compromise in the efforts to balance
stewardship with compassion toward
the emotional needs of grieving loved

ones.
Another important aspect of Holy
Cross’s process is absolute clarity
that physicians, rather than ethics
committee members, determine that
a patient is in a terminal, end-stage,
or vegetative condition, or that a
particular intervention is medically
ineffective. The ethics consultants
may advise that additional medical
consultation (e.g., neurology) confirm
a treating physician’s determination,
but those requesting an ethics
consultation need to understand that
the practice of medicine resides with
clinicians.
Cont. on page 8

HOLY CROSS HOSPITAL’S PROCESS FOR WITHHOLDING/WITHDRAWING
MEDICALLY INEFFECTIVE TREATMENT
Step 1 – Data Collection
An ethics committee member (at Holy Cross Hospital this is often a physician, to allow direct physician-to-physician
communication) collects relevant information from the medical chart and from stakeholders, visits the patient,
reviews any advance directive or MOLST documents, identifies a surrogate decision-maker (if the patient lacks
decision-making capacity), and reviews certifications for capacity, condition, and medically ineffective treatment. If
there are no certifications yet completed, the consultant asks the physician whether he or she is willing to complete
certifications if appropriate. The consultant may convene a meeting of the ethics committee if needed. A palliative
care consultation may be recommended if not yet done. Recommendations are made and a written consultation note
is placed on the chart, after first being reviewed by the Vice President of Mission Services, Vice President of Spiritual
Care and Ethics, and Risk Management.
Step 2 – Negotiate Goals of Care
An ethics consultation regarding withholding or withdrawing medically ineffective treatment occurs when a patient
or surrogate disagrees with the physician’s decision to withhold or withdraw treatment. Thus, an attempt is made
to mediate this conflict by negotiating achievable goals of care, sometimes by facilitating a family meeting. Those
involved often include the palliative care team, the patient’s own primary care physician, chaplaincy, and the patient’s
own clergy. If, based on negotiations surrounding goals of care for the patient, the patient/surrogate agrees to withhold
or withdraw medically ineffective treatment, the ethics consultation is complete. If the patient/family continues to
insist that medically ineffective interventions be provided, they are informed that certain treatments may be withheld
or withdrawn despite their wishes using the process defined in Maryland’s HCDA, including the option of transfer.
Step 3 – Implementation
At this point, all appropriate certifications are completed (e.g., patient incapacity; patient condition, i.e., terminal
condition, end-stage condition, vegetative state, or medically ineffective treatment). Holy Cross has developed
forms to use for these certifications. The patient or surrogate is informed of treatments to be withheld or withdrawn
and is given a reasonable period of time, usually one week, to find a physician and facility willing to provide those
treatments. All disputed treatments are provided during that time. Holy Cross will facilitate transfer if one is found. A
letter from Senior Management is given to the patient or surrogate explaining this. If an alternative facility cannot be
found, orders to withhold/withdraw medically ineffective treatment(s) are written, the patient or surrogate is informed,
and the disputed treatments are withheld or withdrawn, with appropriate spiritual and palliative care provided.
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Medically Ineffective Treatment
Cont. from page 7
Components of Holy Cross’s
process that Dr. Schwab identified
as being particularly instrumental in
its success include having specific
wording in ethics consultation notes
that physicians find supportive of
medically ineffective treatment
determinations, use of a standardized
Certification of Medically Ineffective
Treatment form, and administrative
support in the form of a letter given
to the patient’s surrogate signed by
a member of Senior Management,
affirming the physician’s plan to
withhold/withdraw treatment by a
given date unless transfer can be
arranged.
Dr. Schwab noted that this process
has been helpful when the surrogate
feels overburdened by having to make
decisions about whether their loved
one lives or dies, or when a surrogate
feels pressured by family or culture
to choose aggressive life-prolonging
treatments for the patient. Having
the physician make the decision may
remove the burden from the surrogate.
It has also been helpful in some cases
where there is no surrogate and the
patient is appropriate for “comfort care
only,” as it precludes going to court to
have a guardian appointed. However,
staff need to be prepared to handle
feelings of anger and resentment
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among some
family members
who disagree
with decisions
to withhold
or withdraw
non-beneficial
interventions from
their loved one.
While Maryland’s
HCDA does not
specify a period
of time to await
transfer if a
surrogate disagrees
with a decision
to withhold or withdraw medically
ineffective treatment, Holy Cross
typically allows a seven day period
for patients who are hemodynamically
stable (i.e., if no transfer can be
arranged within that time period,
the medically ineffective treatment
will be withheld or withdrawn after
seven days). For patients who are
actively dying and hemodynamically
unstable, physicians may determine
that transfer is not an option and
institute “no escalation of treatment”
upon informing the surrogate of
this decision. During the discussion
period following Dr. Schwab’s talk
at the December 9, 2013 MOLST
conference, Jack Schwartz (formerly

with the Maryland State Attorney
General’s office) opined that he
viewed this as consistent with the
HCDA because the reference to
“pending transfer” in Maryland’s
HCDA should be interpreted as
awaiting a planned transfer, which
wouldn’t apply in the case of a patient
with no available transfer options.
To view Dr. Schwab’s presentation,
visit MHECN’s website at http://www.
law.umaryland.edu/mhecn and click
on “Conferences.”

CASE PRESENTATION
One of the regular features of this Newsletter is the presentation of a case considered by an ethics committee and an
analysis of the ethical issues involved. Readers are both encouraged to comment on the case or analysis and to submit
other cases that their ethics committee has dealt with. In all cases, identifying information about patients and others in the
case should only be provided with the permission of the patient. Unless otherwise indicated, our policy is not to identify
the submitter or institution. We may also change facts to protect confidentiality. Cases and comments should be sent to
MHECN@law.umaryland.edu, or MHECN, Law & Health Care Program, University of Maryland Francis King Carey
School of Law, 500 W. Baltimore St., Baltimore, MD 21201.
NOTE: A Maryland physician was
involved in the case below while
working in another state. The
hospital's ethics committee was not
involved. Details have been changed
to protect confidentiality.
Antonia is a 34 year old woman
who is 11 weeks pregnant with twins
and hospitalized for complications
of pregnancy. The amniotic sac for
Twin A has ruptured, but the sac for
Twin B is intact. Based on available
outcomes literature, Twin A is not
expected to survive. Thus, only Twin
B is being monitored (via ultrasound
once per shift). Antonia is put on
inpatient bedrest to minimize the risk
that Twin B’s sac will prematurely
rupture. A neonatal intensive care
unit (NICU) fellow is consulted on
the case. She proposes that starting
at 24 weeks, the team could begin
monitoring Twin A and, if either
twin showed signs of distress, could
deliver both twins early. Antonia,
an undocumented immigrant from
Mexico who does not speak English,
is a devout Catholic. She considers
that not intervening to try to save
Twin A would be like “killing” the
baby, and that even though an early
delivery would threaten the life of
either twin, she must try to save them
both. She requests that both twins be
monitored starting at 24 weeks, with
the expectation that they be delivered
via cesarean section if either show
signs of distress. The neonatologists,
while concerned that there isn’t really
a reasonable chance that they can save
Twin A, feel that the team made this
promise to Antonia and they can’t

go back on it. A NICU resident calls
a member of the ethics consultation
service to discuss the ethics of this
situation. She reasons that since it’s
almost a certainty that Twin A will die
regardless of any intervention, there
is no benefit to Twin A from the early
delivery, but clear harm to Twin B.
RESPONSE FROM A
NEONATOLOGIST & ETHICS
COMMITTEE MEMBER
The past two decades have seen
a near doubling in rates of multiple
births across the U.S. and many
European countries (Kulkarni, 2013;
Boyle, 2013). Some although not all
of this increase is the result of growing
use of assisted reproduction—
technologies with inherent risks of
multiple gestation. Multiple gestations
have higher rates of congenital
anomalies and premature birth than
do singleton pregnancies. Usually
only one fetus will be affected by the
anomaly or premature rupture of the
amniotic sac. Hence, it is increasingly
common that parents and clinicians
face decisions about how to balance
competing interests of the affected
fetus and the unaffected fetus(es)—
and how to balance these with the
interests of the mother. The literature
in perinatal and pediatric bioethics
lags behind this clinical trend, with
most discussions of prenatal decisionmaking limited to maternal-fetal
conflicts in singleton pregnancies.
In the case presented here,
premature rupture of the amniotic sac
for Twin A occurred at 11 weeks, and
we assume there is minimal residual
amniotic fluid. Antonia does not

appear to be in labor, so the pregnancy
could continue for days, weeks, or
months. Amniotic fluid is critically
important to fetal lung development;
without adequate amniotic fluid in the
second trimester, fetal lung formation
is severely limited. The overwhelming
majority of such infants will die before
or soon after birth. Rarely, a ruptured
amniotic sac can reseal and amniotic
fluid reaccumulate; we are not told
that this occurred for Antonia. Some
small studies suggest that repeated
fluid infusions into the uterus until
birth can permit neonatal survival
for a minority (Locatelli, 2000). For
Antonia, this therapy would be yet
another intervention with questionable
benefit for Twin A and risk for Twin B.
In sum, there are no interventions to
give Twin A even a modest chance of
survival.
Neither of Antonia’s twins is viable
at 11 weeks, but her pregnancy could
continue for months. In general,
prior to 23 weeks gestation, neonatal
survival is extremely rare and so
resuscitation is typically not offered
by U.S. clinicians. After 25 weeks,
neonatal survival is greater than
50% and so most clinicians feel that
resuscitation should be attempted.
Between 23-25 weeks, neonatal
survival is low but possible, so the
standard of care is to allow families
to participate in decisions about
resuscitation based on their goals
and values. These management
guidelines must be amended when
the fetus has another condition which
Cont. on page 10
Mid-Atlantic Ethics Committee Newsletter 9

Case Presentation
Cont. from page 9
impacts morbidity or mortality—
such as Twin A’s abnormal lung
development. There are no objective
data to guide resuscitation decisions
in these situations. If Antonia went
into spontaneous labor at 24 weeks,
and greatly desires resuscitation for
both twins, it is likely that some or
most of the neonatologists would
have complied with that request.
Twin A may not survive resuscitation,
but in the case of spontaneous labor,
resuscitation of Twin A does not
directly harm Twin B.
The issue in this case that most
clearly pits the interests of Twin
A, Twin B, and the mother against
each other is the issue of premature
cesarean section. Cesarean section
after premature rupture of membranes
can improve survival if fetal health is
deteriorating. Prior to 24 weeks, the
maternal risk from cesarean section is
thought to be higher than the chances
for neonatal survival, hence surgical
delivery is usually only offered after
24 weeks. In a multiple gestation,
where only one fetal sac has ruptured,
premature cesarean section to optimize
survival of that fetus necessarily
imposes the risks of prematurity on
the other fetus(es), who may not have
delivered until term. For Antonia,
should both fetuses survive beyond 24
weeks, Twin A will be the most likely
to demonstrate fetal distress.
This case touches on the important
question of whether it is permissible
for a pregnant woman to place a
healthy fetus at risk of death in
an attempt to save a fetus who is
unlikely to survive (Chervenak,
2013). Unfortunately, this option
was presented as a valid choice to
Antonia before team consensus
about that option was achieved.
Predictably, in the face of an ethically
complex medical case, there are
divergent opinions among medical
team members about what options
10 Mid-Atlantic Ethics Committee Newsletter

are permissible. Ideally, team
members will convene to discuss and
reach consensus about permissible
and recommended management
plans before presenting options
to the patient. Interdisciplinary
team members, trainees, and ethics
consultants should all be invited to
engage in this process. Clearly some
clinicians in this case do not agree
with the option of cesarean section to
save Twin A. When a controversial
management plan is offered to a
patient without team consensus,
iatrogenic harm can occur.
Much is unknown about Antonia, the
circumstances of her pregnancy, her
social supports, or her Catholic beliefs.
Few pregnant women are prepared for
the possibility of extremely premature
labor and months of bedrest with
the impact on jobs, childcare, and
finances. Antonia is an undocumented
immigrant from Mexico, and is
likely to have experienced economic
insecurity, limited access to healthcare
including prenatal care, and multiple
social stressors. Identifying persons
who can partner with her in these
difficult decisions is crucial because
she may lack cultural context for
sharing serious medical decisions.
Her Catholic beliefs appear to be
important to her; involving a hospital
or community priest may reduce
Antonia’s suffering and can help
navigate discussions about hope
and quality of life. Antonia does not
speak English, which may weaken
understanding between the patient and
the medical team.
A significant question about
communication in this case revolves
around the issue of what clinicians
have told Antonia will happen to
or for Twin A if resuscitation is not
attempted. Too often this decision is
posed as “do nothing,” suggesting
that clinicians will abandon the infant
after birth. A more skilled approach
will emphasize the actions that can

be taken to minimize suffering and
maximize comfort, bonding, and
memory making, so that the infant’s
life is filled with love and gentleness.
Perinatal palliative care could begin
from the moment of diagnosis, from
the moment that Antonia was admitted
with pregnancy complications.
Irrespective of the pregnancy
decisions or outcomes, palliative care
can provide support and continuity and
can ease suffering. These services are
increasingly available though inpatient
consultation or through relationships
with local hospices.
Renee Boss, MD, MHS
Assistant Professor,
Division of Neonatology
Johns Hopkins School of Medicine
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COMMENTS FROM A
CATHOLIC BIOETHICIST
Antonia’s dilemma sheds light
on three important facets of clinical
bioethics, including the benefit of
having faith-trained ethicists, the
ability to end an error chain before
the error occurs, and the necessity to
correct mistakes in a timely manner.

This case presents a complex,
controversial ethical situation and
Antonia’s devout religious beliefs
are truly admirable. It should be
noted, though, that although Antonia
believes attempting to save both
twins is mandatory according to
her Catholic faith, there are in fact
provisions in Catholic doctrine that
make it permissible to jeopardize the
health of one twin for clear benefit to
the other. It is certainly true that every
human being has a fundamental right
to life and that Catholics believe in
the dignity of life from conception
to natural death, but it is equally true
that the ethical principle of double
effect offers an acceptable solution to
this complicated situation. Originally
outlined by St. Thomas Aquinas in
his work Summa Theologica, this
principle offers an understanding of
actions that have both an intended
good effect and an unintended evil
effect. The principle’s concept—that
foreseen harm can be done as long
as the harm is unintended and the
intended good is commensurable—
corresponds to the circumstances
of this case very well. Indeed, the
good of saving Twin A’s life is surely
proportionate to losing Twin B, as sad
and unfortunate as that outcome is
(Paris & Elias-Jones, 2001). Without
knowing more specifics of the case,
but assuming nothing harmful was
intentionally or directly done to
Twin A, application of the principle
of double effect instructs us that
delivering Twin B at 25 weeks or
soon thereafter (as warranted by the
ultrasound monitoring), even with
the probable demise of Twin A, is
wholly permissible in accordance with
Catholic theology (Annas, 2007).
In addition to the principle of double
effect, the principle of proportionality
must also be considered. The fact of
the matter is that early delivery is
disproportional for both Twin A and
Twin B. The advertised and requested

treatment is
disproportional
for Twin A
because it is not
likely to help,
is very invasive
and expensive,
and, more
abstractly, would
not result in a
‘good’ death.
Similarly, it is
disproportional
for Twin B
because it carries extreme risk (so
much so that the benefits do not
outweigh the risks) and is equally as
invasive and expensive as for Twin
A. In this case study, an ethicist with
a background in Catholic healthcare
ethics would have been immensely
helpful to correct the inaccuracies
in Antonia’s perception of Catholic
bioethics. In this way, faith-trained
ethicists have the capability (and
moral obligation) to correct a patient’s
misunderstanding by explaining
the medical treatments available to
the patient and to walk through the
morality of each according to the
specific faith’s doctrine.
Although not an ethical principle,
another major theme to extract from
this case study is the responsibility
of health care teams to recognize
potential mistakes before they occur
since the Harvard Medical Practice
study concluded that 90% of medical
errors are preventable (Wolf &
Hughes, 2010). The necessity to
correct mistakes in a timely manner
is a concept that seems intuitively
simple and somewhat obvious, but
can be surprisingly difficult in clinical
situations. Admitting a mistake is
never easy, of course, and in the case
of medical mistakes, is fraught with
worry about lawsuits. Nevertheless,
mistakes that could harm a patient
must be counteracted and negated as
soon as they are recognized. Indeed,

mistakes simply never get better
with time and an empty promise of a
medical treatment is better than the
loss of a life.
Recognition of the mistake becomes
increasingly difficult with larger
healthcare teams. Coming from a
military background, I apply the term
“error chain” to this problem. That is,
each person involved with the care of
Antonia and her twins has the ability
to halt the series of decisions before it
results in a medical error. Since each
decision might be small in nature and
seemingly insignificant unless taken
in aggregate with the other small
decisions, error chains are notoriously
difficult to identify. Here, in this case,
the doctors, nurses, family members,
on-call ethicist, and ethics committee
members all had an opportunity to
identify the mistake of suggesting both
twins could be monitored starting at 25
weeks. In other words, they could have
corrected that promise either before
the patient requested monitoring or
before the healthcare team assented to
the monitoring, and therefore before
anyone ultimately inflicted harm to
Twin B.
The expanding number of people
involved in many of these ethically
challenging cases begs the question,
“Who is best suited for identifying
the mistake?” Arguably, this
responsibility falls particularly on
the shoulders of the ethicist because
Cont. on page 12
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the ethicist’s fresh eyes approach
the case without being intricately or
emotionally involved with the day-today care of the patient. They bring to
the problem a top-down rather than
a bottom-up perspective, and this
change in thinking permits an opening
that might be closed to others. In
order for ethicists to capitalize on that
opening, they should never become
complacent consulting on cases.
As ethicists trained to analyze the
facts of the case and offer a decision
best for the patient based on the
circumstances at hand, it is imperative
that their judgment is not excessively
influenced by the information they
gather from others on the health care
teams. Doing so will increase the
chance of glossing over the error.
Instead, they must ask pertinent

questions and examine the entirety
of the case for themselves whenever
possible so that the succession of
small decisions is seen as a whole and
the medical mistake is more easily
caught. Despite the physician actually
disclosing the error to the patient, the
ethicist plays an important role in the
process of identifying the error and
must be firm when discussing his or
her recommendations with others. To
be clear, this certainly does not clear
other healthcare team members of
all responsibility, but instead merely
lessens the degree of expectation
that they would be able to catch the
error. It also highlights the necessity
of encouraging open communication
among all healthcare team members so
that anyone who discovers the mistake
feels comfortable enough to bring it to

the attention of the physician.
Kathleen M. Gilpin
PhD Candidate for Neuroscience
University of Maryland School
of Medicine
Ethics Consultant Intern
Anne Arundel Medical Center
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CALENDAR OF EVENTS
FEBRUARY
24 (12:15-1:30P)
Disparate Views on the End of Life. Bioethics seminar speaker Sarah Shannon, PhD, RN, sponsored by The Johns
Hopkins Berman Institute of Bioethics, 615 N. Wolfe Street, Baltimore, MD, W3008. For more information, visit
http://www.bioethicsinstitute.org/.
14 (4-8P)
Bioethics Colloquium with Dave Wendler, sponsored by the Center for Bioethics, New York University, New
York, NY. For location & further information, and to RSVP, visit http://bioethics.as.nyu.edu/page/events.
27
Do Emotions Derail Rationality? Webinar discussing article “When concretized emotional-belief complexes derail
decision-making capacity,” in Bioethics, 2012, 26(2), 108-16, with author Jodi Halpern, MD, PhD. Sponsored by
the American Journal of Bioethics. For time and registration information, contact cmbc@cmh.edu, call 816-7015285, or visit https://cmhbioethicswebex.com/.
MARCH
6
The Culture of Dysthanasia. Webinar discussing article “The cuture of dysthanasia: attempting CPR in terminally
ill children,” in Pediatrics, 2013, 131(3), 572-80, with co-author Jonna Clark, MD, MA. Sponsored by the
American Journal of Bioethics. For time and registration information, contact cmbc@cmh.edu, call 816-7015285, or visit https://cmhbioethicswebex.com/.
7 (4-7P)
Bioethics Colloquium with Dan Brock, sponsored by the Center for Bioethics, New York University, New York,
NY. For location & further information, and to RSVP, visit http://bioethics.as.nyu.edu/page/events.
12 Mid-Atlantic Ethics Committee Newsletter

7-9
Responding to the Limits and Possibilities of the Body, 3rd Annual Conference on Medicine & Religion. Hyatt
Chicago Magnificent Mile, Chicago, IL. For more information, visit http://www.medicineandreligion.com/
registration.html.
8
Difficult Conversations in Healthcare: Teaching and Practice, sponsored by the Institute for Professionalism &
Ethical Practice, Boston Children’s Hospital and Harvard Medical School. Waltham, MA. Course repeats on May
17 and June 7. For more information, visit http://www.hms-cme.net/3424265/3424265_emailindex2.html.
10 (12:15-1:30P)
Dignity for Patients in the ICU: A Conceptual Model. Bioethics seminar speaker Leslie Meltzer-Henry, JD,
sponsored by The Johns Hopkins Berman Institute of Bioethics, 615 N. Wolfe Street, Baltimore, MD, W3008. For
more information, visit http://www.bioethicsinstitute.org/.
19
Dangerousness & Involuntary Treatment: An Applied Ethics Workshop, sponsored by the University of
Pennsylvania’s Department of Medical Ethics & Health Policy, Claudia Cohen Hall, Terrace Room, Philadelphia,
PA. For more information, visit medicalethics.med.upenn.edu.
20-21
Embracing Change: Balancing Innovation and Our Humanity. Health Care Ethics Consortium’s Annual
Conference. Sponsored by Emory University’s Center for Ethics and the Health Care Ethics Consortium of
Georgia (HCECG). Atlanta, Georgia. For more information, visit www.hcecg.org .
APRIL
1-4
Public Health Ethics Intensive, sponsored by the National Center for Bioethics in Research and Health Care
located at Tuskegee University. For more information, visit http://www.tuskegee.edu/about_us/centers_of_
excellence/bioethics_center.aspx.
11 (4:30-7P)
Bioethics Colloquium with Maggie Little, sponsored by the Center for Bioethics, New York University, New
York, NY. For location & further information, and to RSVP, visit http://bioethics.as.nyu.edu/page/events.
14 (12:15-1:30P)
Moving Beyond Futility: Resolving intractable clinician-family disputes in patients with advanced critical illness.
Bioethics seminar speaker Doug White, MD, sponsored by The Johns Hopkins Berman Institute of Bioethics, 615
N. Wolfe Street, Baltimore, MD, W3008. For more information, visit http://www.bioethicsinstitute.org/.
23
Ethical Dilemmas in the Practice of Obstetrics, Gynecology & Reproductive Medicine, Sponsored by the
Cleveland Clinic, Cleveland, Ohio. For more information, visit http://www.clevelandclinicmeded.com/live/
courses/2014/obgyn14/default.asp.
24-25
Ethics Problem Solving and Consultation: The Mayo Approach. Sponsored by The Mayo Clinic, Rochester, MN.
For more information, visit http://www.mayo.edu/cme/special-topics-in-health-care-2014r571.
25-26
Symposium on Ethics and Mental Health, Marietta, OH. For more information, contact akp004@marietta.edu.

Cont. on page 14
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APRIL (cont'd)

CALENDAR OF EVENTS (cont'd)

28 (12:15-1:30P)
The Ethics of Personal Responsibility. Bioethics seminar speakers Diane Hoffman, JD, MS & Janyne Althaus,
MD, sponsored by The Johns Hopkins Berman Institute of Bioethics, 615 N. Wolfe Street, Baltimore, MD,
W3008. For more information, visit http://www.bioethicsinstitute.org/.
MAY
1-2
New Stressors and Solutions in Health Care Ethics, sponsored by the Colorado Healthcare Ethics Forum (CHEF),
Thornton, CO. For more information, visit http://coloradoethicsforum.org/.
8-10
Ways and Means: Teaching Professionalism Across the Health Care Spectrum, 2nd annual meeting of the
Academy for Professionalism in Health Care. Hilton Garden Inn, Chicago, IL. For more information, visit http://
academy-professionalism.org/index_/2014_Annual_Meeting.html.
12 (12:15-1:30P)
Berman Bioethics Seminar speaker Brad Malin, PhD (biomedical informatics), sponsored by The Johns Hopkins
Berman Institute of Bioethics, 615 N. Wolfe Street, Baltimore, MD, W3008. For more information, visit http://
www.bioethicsinstitute.org/.
17
Difficult Conversations in Healthcare: Teaching and Practice, sponsored by the Institute for Professionalism &
Ethical Practice, Boston Children’s Hospital and Harvard Medical School. Waltham, MA. Course repeats on June
7. For more information, visit http://www.hms-cme.net/3424265/3424265_emailindex2.html.
19-20 (and June 16-17)
4 Day Intensive Course in Bioethics Consultation Skills, sponsored by Montefiore-Einstein Center for Bioethics,
New York, NY. Pre-requisite Montefiore-Einstein Certificate Program in Bioethics and Medical Humanities or
permission of instructor. For more information, visit http://www.einstein.yu.edu/masters-in-bioethics.
25-30
Medical Humanities: Clinical & Pedagogical Perspectives, sponsored by the Doctors Kienle Center for
Humanistic Medicine, Penn State College of Medicine, Hershey, PA. For more information, contact
kienlecenter@hmc.psu.edu or visit http://www2.med.psu.edu/humanities/kienle-symposium.
26 (12:15-1:30P)
Berman Bioethics Seminar, sponsored by The Johns Hopkins Berman Institute of Bioethics, 615 N. Wolfe Street,
Baltimore, MD, W3008. For speaker information and topic, visit http://www.bioethicsinstitute.org/.
28-31
The 25th Annual Canadian Bioethics Society Conference: Looking Back; Looking Forward. Renaissance
Vancouver Harbourside Hotel, Vancouver, CA. For more information, visit www.cbs-scb2014.ca.
JUNE
2-6
Intensive Bioethics Course sponsored by the Kennedy Institute of Ethics, Georgetown, MD. For more
information, visit http://kennedyinstitute.georgetown.edu/programs/ibc.cfm .
7
Difficult Conversations in Healthcare: Teaching and Practice, sponsored by the Institute for Professionalism &
Ethical Practice, Boston Children’s Hospital and Harvard Medical School. Waltham, MA. For more information,
visit http://www.hms-cme.net/3424265/3424265_emailindex2.html.
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8-27
Bioethics Boot Camp at the University of Pensylvania, sponsored by the University of Pennsylvania’s
Department of Medical Ethics & Health Policy. Applications due February 17. For more information, visit
medicalethics.med.upenn.edu.
9 (12:15-1:30P)
Berman Bioethics Seminar, Berman Bioethics Seminar speaker Brad Malin, PhD (biomedical informatics),
sponsored by The Johns Hopkins Berman Institute of Bioethics, 615 N. Wolfe Street, Baltimore, MD, W3008.
For more information, visit http://www.bioethicsinstitute.org/.
23 (12:15-1:30P)
Berman Bioethics Seminar, sponsored Berman Bioethics Seminar, sponsored by The Johns Hopkins Berman
Institute of Bioethics, 615 N. Wolfe Street, Baltimore, MD, W3008. For speaker information and topic, visit
http://www.bioethicsinstitute.org/.
26-28
Comics & Medicine: From Private Lives to Public Health. Sponsored by The Johns Hopkins University
School of Medicine Department of Art as Applied to Medicine in collaboration with Graphic Medicine, at the
Johns Hopkins Medical Campus, Baltimore, MD. For more information, visit http://www.graphicmedicine.
org/comics-and-medicine-conferences/2014-baltimore-conference/.

The Maryland Healthcare Ethics Committee Network (MHECN) is a membership organization, established by
the Law and Health Care Program at the University of Maryland Francis King Carey School of Law. The purpose
of MHECN is to facilitate and enhance ethical reflection in all aspects of decision making in health care settings
by supporting and providing informational and educational resources to ethics committees serving health care
institutions in the state of Maryland. The Network attempts to achieve this goal by:
• Serving as a resource to ethics committees as they investigate
ethical dilemmas within their institution and as they strive to assist
their institution act consistently with its mission statement;
• Fostering communication and information sharing among Network
members;
• Providing educational programs for ethics committee members, other
healthcare providers, and members of the general public on ethical
issues in health care; and
• Conducting research to improve the functioning of ethics committees
and ultimately the care of patients in Maryland.
MHECN appreciates the support of its individual and institutional members. MHECN also welcomes support from
affiliate members who provide additional financial support.
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